newsfilter
← Latest News
GlobeNewswire·

Cerecor Doses First Patient in a Phase 1b Proof-of-Concept Clinical Trial of CERC-007 for the Treatment of Adult Onset Still's Disease

Initial data anticipated in the third quarter of 2021 Top-line data from the ongoing Phase 1b proof of concept clinical trial in relapsed or refractory multiple myeloma patients anticipated in the second half of 2021 ROCKVILLE, Md. and